1. Home
  2. AGEN vs LASE Comparison

AGEN vs LASE Comparison

Compare AGEN & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGEN
  • LASE
  • Stock Information
  • Founded
  • AGEN 1994
  • LASE 2019
  • Country
  • AGEN United States
  • LASE United States
  • Employees
  • AGEN N/A
  • LASE N/A
  • Industry
  • AGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • LASE Industrial Machinery/Components
  • Sector
  • AGEN Health Care
  • LASE Industrials
  • Exchange
  • AGEN Nasdaq
  • LASE Nasdaq
  • Market Cap
  • AGEN 96.2M
  • LASE 80.9M
  • IPO Year
  • AGEN 2000
  • LASE 2022
  • Fundamental
  • Price
  • AGEN $2.86
  • LASE $6.05
  • Analyst Decision
  • AGEN Buy
  • LASE
  • Analyst Count
  • AGEN 3
  • LASE 0
  • Target Price
  • AGEN $9.33
  • LASE N/A
  • AVG Volume (30 Days)
  • AGEN 576.6K
  • LASE 425.3K
  • Earning Date
  • AGEN 11-12-2024
  • LASE 11-14-2024
  • Dividend Yield
  • AGEN N/A
  • LASE N/A
  • EPS Growth
  • AGEN N/A
  • LASE N/A
  • EPS
  • AGEN N/A
  • LASE N/A
  • Revenue
  • AGEN $160,427,000.00
  • LASE $3,141,411.00
  • Revenue This Year
  • AGEN N/A
  • LASE N/A
  • Revenue Next Year
  • AGEN $0.04
  • LASE N/A
  • P/E Ratio
  • AGEN N/A
  • LASE N/A
  • Revenue Growth
  • AGEN 59.00
  • LASE 5.21
  • 52 Week Low
  • AGEN $2.50
  • LASE $0.69
  • 52 Week High
  • AGEN $19.69
  • LASE $19.80
  • Technical
  • Relative Strength Index (RSI)
  • AGEN 28.17
  • LASE 51.45
  • Support Level
  • AGEN $2.50
  • LASE $4.94
  • Resistance Level
  • AGEN $2.89
  • LASE $5.39
  • Average True Range (ATR)
  • AGEN 0.29
  • LASE 0.48
  • MACD
  • AGEN -0.07
  • LASE 0.17
  • Stochastic Oscillator
  • AGEN 18.75
  • LASE 98.61

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, primarily laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

Share on Social Networks: